Strain Information | |
---|---|
Image | |
BRC No. | RBRC02091 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | STOCK Pcdha<tm5.1Tyag> Olfr151<tm25Mom>/TyagRbrc |
Former Common name | M71-LacZ/dA |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Takeshi Yagi, Graduate School of Frontier Biosciences, Osaka University. The mutant mice were generated by crossing with CNR delta A (RBRC01691) (Takeshi Yagi, Graduate School of Frontier Biosciences, Osaka University) and M71-lacZ (Peter Monbaerts, The Rockefeller University) mice. |
Strain description | CNR (Pcdha) delta A mutant and M71 (Olfr151) gene ires-taulacZ knock-in double mutant mice. |
Colony maintenance | Pcdha: Homozygote x Homozygote; Olfr151: Homozygote x Homozygote |
References | Mol Cell Neurosci, 38, 66-79 (2008). 18353676 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP18loxP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter IRESinternal ribosomal entry site (EMCV)9internal ribosomal entry site from EMCV Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter lacZbeta-galactosidase (E. coli)9 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP9loxP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter taubovine tau protein cDNA9tau |
Ordering Information | |
---|---|
Donor DNA | Phage P1 loxP, E. coli lacZ, Encephalomyocarditis virus (EMCV) internal ribosomal entry site (ires),bovine tau cDNA, mouse Olfr151 genomic DNA, mouse Pcdha genomic DNA |
Research application | Cre/loxP system Fluorescent Proteins/lacZ System Neurobiology Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. The RECIPIENT of BIOLOGICAL RESOURCE must obtain a prior consent on use of it from Professor Peter Monbaerts, The Rockefeller University. If the RECIPIENT's research results in an invention based on the BIOLOGICAL RESOURCE, the RECIPIENT must contact DEPOSITOR to negotiate the treatment of such invention. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, the RECIPIENT must obtain a prior written consent from the DEPOSITOR. The RECIPIENT, which wishes to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research, is requested to enter into a Material Transfer Agreement with Osaka University. |
Depositor | Takeshi Yagi (Osaka University) |
Strain Status | Frozen embryos |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |